New patent expiration for Teva Womens drug ADDERALL 10
Annual Drug Patent Expirations for ADDERALL+10 Adderall 10 is a drug marketed by Teva Womens and is included in one […]
New patent expiration for Teva Womens drug ADDERALL 10 Read Post »
Annual Drug Patent Expirations for ADDERALL+10 Adderall 10 is a drug marketed by Teva Womens and is included in one […]
New patent expiration for Teva Womens drug ADDERALL 10 Read Post »
Annual Drug Patent Expirations for ADDERALL+12.5 Adderall 12.5 is a drug marketed by Teva Womens and is included in one
New patent expiration for Teva Womens drug ADDERALL 12.5 Read Post »
Annual Drug Patent Expirations for ADDERALL+12.5 Adderall 12.5 is a drug marketed by Teva Womens and is included in one
New patent expiration for Teva Womens drug ADDERALL 12.5 Read Post »
Annual Drug Patent Expirations for ADDERALL+15 Adderall 15 is a drug marketed by Teva Womens and is included in one
New patent expiration for Teva Womens drug ADDERALL 15 Read Post »
Annual Drug Patent Expirations for CLEVIPREX Cleviprex is a drug marketed by Chiesi and is included in one NDA. It
CLEVIPREX (clevidipine) Chiesi Patent: 5,856,346 Expiration: Jan 5, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of January 3, 2021 Read Post »
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA.
New patent expiration for Jazz Pharms drug XYREM Read Post »
CLEVIPREX (clevidipine) Chiesi Patent: 5,856,346 Expiration: Jan 5, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of January 3, 2021 Read Post »
Annual Drug Patent Expirations for XYREM Xyrem is a drug marketed by Jazz Pharms and is included in one NDA.
New patent expiration for Jazz Pharms drug XYREM Read Post »
Get fresh news and insights, drug patent expirations & more…